Filing Details

Accession Number:
0001203311-17-000038
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-09 18:52:01
Reporting Period:
2017-08-07
Filing Date:
2017-08-09
Accepted Time:
2017-08-09 18:52:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seattle Genetics Inc SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1633639 S Darren Cline 21823 30Th Drive Se
Bothell WA 98021
Evp, Commercial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-07 6,000 $18.46 67,656 No 4 M Direct
Common Stock Disposition 2017-08-07 6,000 $49.19 61,656 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-08-07 6,000 $0.00 6,000 $18.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,907 2022-02-28 No 4 M Direct
Footnotes
  1. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 105 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on July 31, 2017.
  2. Shares vested at a rate of 25% on 2/28/2013 and monthly thereafter until all the shares were fully vested on 2/28/2016.